SEC Tracker
Get the app

Panamera Holdings PHCI

Panamera Holdings Q3 FY26: revenue $0; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Panamera Holdings reported for Q3 FY26, the quarter ended Apr 30, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$0−100% from $110K in Q3 FY2510-Q income statement, on EDGAR
  2. Net income−$117KAgainst −$116K in Q3 FY2510-Q income statement, on EDGAR
  3. Diluted EPS$0.00Against $0.00 in Q3 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$46−100% from $150K in Q3 FY2510-Q balance sheet, on EDGAR
  5. Cash from operations−$45KAgainst −$167K in Q3 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Panamera Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.

  1. Pharma-Bio Serv PBSV public float $14M, Apr 30, 2025, over 18 months old
  2. RTB Digital RTB public float $9M, Jun 30, 2025
  3. Elvictor Group ELVG public float $8M, Jun 30, 2025
  4. Aeries Technology AERT public float $8M, Sep 30, 2025
  5. Greenpro Capital GRNQ public float $8M, Jun 30, 2025